Company Filing History:
Years Active: 2018
Title: Han Chang Kang: Innovator in Drug Delivery Systems
Introduction
Han Chang Kang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of drug delivery systems, particularly through his innovative approaches to polymer technology. His work focuses on enhancing the efficacy of drug delivery mechanisms, which is crucial for improving therapeutic outcomes.
Latest Patents
Han Chang Kang holds a patent for a "Reducing or non-reducing polynucleotide polymer for drug delivery and method for preparing same." This invention relates to a polynucleotide polymer that utilizes nucleotides such as AMP, ADP, ATP, GMP, GDP, GTP, CMP, CDP, and CTP, along with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and N-hydroxy-succinimide (NHS). The polymer serves as a drug delivery carrier that can effectively transport proteins or peptides to targeted areas within the body through electrostatic attraction. The polymer is designed to be easily breakable due to disulfide bonds, enhancing its functionality in drug delivery applications.
Career Highlights
Throughout his career, Han Chang Kang has worked with notable institutions, including the Catholic University of Korea Industry-Academic Cooperation Foundation and the Utah-Inha DDS & Advanced Therapeutics Research Center. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in drug delivery systems.
Collaborations
Han has collaborated with esteemed colleagues such as You Han Bae and Ha Na Cho. These partnerships have facilitated the advancement of innovative solutions in drug delivery technologies.
Conclusion
Han Chang Kang is a key figure in the development of advanced drug delivery systems, with a focus on polynucleotide polymers. His innovative patent and collaborative efforts highlight his commitment to improving therapeutic delivery methods. His work continues to influence the field and pave the way for future advancements in drug delivery technologies.